These data confirm the results of a previous study performed by our group, in which Trop-2 expressing cervical cancer cell lines were found highly susceptible to ADCC when exposed to the naked humanized anti-Trop-2 monoclonal antibody hRS717. The gene discussed is TACSTD2; the disease is cervical carcinoma.